Pneumocystis jirovecii Pneumonia in Cancer Patients, a Lethal Yet Fully Preventable Disease: Insights From a Tertiary Cancer Center in East India
Asia-Pacific Journal of Clinical Oncology · 2025
DOI: 10.1111/ajco.14156 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Asia-Pacific Journal of Clinical Oncology, 2025. Verfasst von S Chatterji und 6 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases, Tata Medical Centre, Kolkata, West Bengal, India. Hauptthemen laut MEDLINE: Pneumonia, Pneumocystis, Pneumocystis carinii, Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Pneumocystis jirovecii pneumonia (PCP) is an unrecognized infection in non‐HIV patients, particularly those with solid and hematologic malignancies. These patients experience higher mortality rates. This study aims to describe the incidence, initial characteristics, management, and outcomes of PCP at a tertiary cancer care center.
Methods
This retrospective observational study included all patients who underwent P. jirovecii PCR testing at our center from January 2019 to January 2022. PCP was diagnosed in PCR‐positive patients. Data on demographics, treatment, and outcomes were extracted from medical records. The primary outcomes were ICU admission and 21‐day mortality. Statistical analysis compared PCR‐positive and PCR‐negative patients, with a specific focus on lung cancer patients, and analyzed determinants of 21‐day mortality in PCP patients.
Results
Of the 345 patients suspected of PCP, 54 (15.7%) were diagnosed with PCP. PCP patients were generally older. None of the PCP patients were on prophylaxis, compared to 14.8% of PCR‐negative patients. In lung cancer patients, age and radiotherapy within the past year were significantly associated with a PCP diagnosis. The 21‐day mortality rate among PCP patients was 35.4%. Independent risk factors for mortality included age and hematologic malignancy, while recent chemotherapy and higher neutrophil counts were associated with lower mortality.
Conclusion
PCP is associated with the highest mortality in patients with hematologic malignancies and lung cancer. The findings underscore the importance and efficacy of prophylaxis in at‐risk groups and should raise awareness for the diagnosis of PCP in overlooked populations, such as older cancer patients and those undergoing radiotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Infectious Diseases, Tata Medical Centre, Kolkata, West Bengal, India.
- Infectious and Tropical Diseases Department, Hôpital de la Croix Rousse, Hospices Civils de Lyon, Lyon, France.
- East and North Hertfordshire NHS Trust, Stevenage, UK.
- Clinical Microbiology Department, Tata Medical Centre, Kolkata, West Bengal, India.
- Department of Critical Care Medicine, Tata Medical Centre, Kolkata, West Bengal, India.
- Radiology, Tata Medical Centre, Kolkata, West Bengal, India.
ORCID-Profile: V Franchi
Zitieren
APA
Chatterji, S., Franchi, V., Konnakottu, A. J., Das, P., Mukherjee, S., Bhattacharya, S., & Chatterjee, A. (2025). Pneumocystis jirovecii Pneumonia in Cancer Patients, a Lethal Yet Fully Preventable Disease: Insights From a Tertiary Cancer Center in East India. Asia-Pacific Journal of Clinical Oncology. https://doi.org/10.1111/ajco.14156
Vancouver
Chatterji S, Franchi V, Konnakottu AJ, Das P, Mukherjee S, Bhattacharya S, et al. Pneumocystis jirovecii Pneumonia in Cancer Patients, a Lethal Yet Fully Preventable Disease: Insights From a Tertiary Cancer Center in East India. Asia-Pacific Journal of Clinical Oncology. 2025. doi:10.1111/ajco.14156
BibTeX
@article{Chatterji2025,
author = {Chatterji, S and Franchi, V and Konnakottu, A J and Das, P and Mukherjee, S and Bhattacharya, S and Chatterjee, A},
title = {Pneumocystis jirovecii Pneumonia in Cancer Patients, a Lethal Yet Fully Preventable Disease: Insights From a Tertiary Cancer Center in East India},
journal = {Asia-Pacific Journal of Clinical Oncology},
year = {2025},
doi = {10.1111/ajco.14156}
}
EUVIMED